Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 EUR | 0.00% | -50.00% | -88.89% |
Mar. 06 | Oxurion Raises Additional Funds from Convertible Bonds Issue | MT |
Jan. 23 | Oxurion Seeks Healthcare Mergers Under New Corporate Strategy | MT |
Sales 2021 | 1.13M 1.22M | Sales 2022 | 595K 642K | Capitalization | 7.81M 8.42M |
---|---|---|---|---|---|
Net income 2021 | -29M -31.27M | Net income 2022 | -31M -33.43M | EV / Sales 2021 | 64.8 x |
Net Debt 2021 | 2.11M 2.28M | Net Debt 2022 | 4.42M 4.77M | EV / Sales 2022 | 20.6 x |
P/E ratio 2021 |
-2.39
x | P/E ratio 2022 |
-0.05
x | Employees | 20 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 78.83% |
1 week | -50.00% | ||
Current month | -50.00% | ||
1 month | -66.67% | ||
3 months | -88.89% | ||
6 months | -91.67% | ||
Current year | -88.89% |
Managers | Title | Age | Since |
---|---|---|---|
Ghoson Pascal
CEO | Chief Executive Officer | - | Dec. 27 |
Michael Dillen
SEC | Corporate Secretary | - | 20-02-29 |
Kathleen Paisley
LAW | General Counsel | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Anat Loewenstein
BRD | Director/Board Member | 64 | 23-03-13 |
James Hartmann
BRD | Director/Board Member | 58 | Dec. 27 |
Director/Board Member | - | 23-03-13 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 0.0001 | 0.00% | 21 553 703 |
24-03-27 | 0.0001 | 0.00% | 16,424,430 |
24-03-26 | 0.0001 | 0.00% | 165,238,600 |
24-03-25 | 0.0001 | 0.00% | 87,105,540 |
24-03-22 | 0.0001 | -50.00% | 1,973,627,000 |
Real-time Euronext Bruxelles, March 28, 2024 at 05:23 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-88.89% | 623K | |
+9.16% | 45.97B | |
+53.86% | 43.93B | |
+11.20% | 42.34B | |
-8.59% | 28.27B | |
+16.40% | 27.18B | |
-19.34% | 19.44B | |
+13.95% | 13.83B | |
+31.56% | 12.4B | |
+10.63% | 11.45B |